Stock PYXS PYXIS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-17 EDT 		5-day change 1st Jan Change
3.66 USD -3.43% Intraday chart for Pyxis Oncology, Inc. -7.81% +103.33%
06-10 Pyxis Oncology, Inc. Appoints Michael A. Metzger to Its Board of Directors CI
05-14 Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pyxis Oncology, Inc. Appoints Michael A. Metzger to Its Board of Directors
CI
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
GL
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
GL
Pyxis Oncology : RBC Capital Markets Global Healthcare Conference
PU
Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M
MT
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GL
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
AQ
Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President
CI
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GL
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
AQ
Pyxis Oncology : Stifel 2024 Virtual Targeted Oncology Forum
PU
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
GL
H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating
MT
Health Care Up on Drug Sales Optimism -- Health Care Roundup
DJ
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
GL
Pyxis Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
GL
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PYXS Stock
  4. News Pyxis Oncology, Inc.